Oncology & Cancer

Ecstasy derivative targets blood cancers

(Medical Xpress) -- A team of UWA researchers have found they may be able to alter the club drug ‘ecstasy’ to kill certain types of blood cancers at the same time boosting the potency and reducing the psychoactivity.

Oncology & Cancer

Researchers identify new way to make cancer self-destruct

For years, researchers have been trying to target a gene called MYC that is known to drive tumor growth in multiple cancer types when it is mutated or over-expressed, but hitting that target successfully has proven difficult. ...

Genetics

Staking out unknown genomic territory

Scientists have long known that the human genome is incredibly complex. However, after almost 10 years of hard work, a team of more than 400 scientists at 32 research institutions worldwide has finally made serious headway ...

Genetics

New liver and kidney disease identified

Scientists have identified a new disease in a ground-breaking discovery that could help patients with unexplained liver and kidney problems.

Medical research

Scientists use uterine stem cells to treat diabetes

Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published in the journal Molecular Therapy. The team treated diabetes in ...

page 2 from 40